Back to User profile » Dr Maryam Aalamian-Mattheis

Papers published by Dr Maryam Aalamian-Mattheis:


Indacaterol/glycopyrronium reduces the risk of clinically important deterioration after direct switch from baseline therapies in patients with moderate COPD: a post hoc analysis of the CRYSTAL study

Greulich T, Kostikas K, Gaga M, Aalamian-Mattheis M, Lossi NS, Patalano F, Nunez X, Pagano VA, Fogel R, Vogelmeier CF, Clemens A

International Journal of Chronic Obstructive Pulmonary Disease 2018, 13:1229-1237

Published Date: 16 April 2018

Early bronchodilator action of glycopyrronium versus tiotropium in moderate-to-severe COPD patients: a cross-over blinded randomized study (Symptoms and Pulmonary function in the moRnING)

Marin JM, Beeh KM, Clemens A, Castellani W, Schaper L, Saralaya D, Gunstone A, Casamor R, Kostikas K, Aalamian-Mattheis M

International Journal of Chronic Obstructive Pulmonary Disease 2016, 11:1425-1434

Published Date: 28 June 2016